Evaluating AGuIX® Nanoparticles in Combination With Stereotactic Radiation for Brain Metastases
NCT04094077 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2021-06-08
Summary
This study evaluates the clinical impact of AGuIX® nanoparticles in combination with Fractionated Stereotactic Radiation in oligo brain metastases.
Conditions
Interventions
- DRUG
-
AGuIX
2 IV injections (100 mg/Kg/injection) at day 4 and day 8 + Strereotactic Radiation from day 8 to day 15 as per standard practice.
Sponsors & Collaborators
-
Centre Leon Berard
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-01-17
- Primary Completion
- 2021-02-24
- Completion
- 2021-02-24
Countries
- France
Study Locations
More Related Trials
-
Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
NCT04121455 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
NCT07098806 ·Status: RECRUITING ·Phase: PHASE1
-
Cranial Radiotherapy or Intensive Chemotherapy With Hematopoietic Stem Cell Rescue for Primary Central Nervous System Lymphoma in Young Patients
NCT00863460 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
NCT06356883 ·Status: RECRUITING ·Phase: PHASE2
-
A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression
NCT06828341 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
NCT01507506 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma
NCT01349036 ·Status: TERMINATED ·Phase: PHASE2
-
Expanded Access to ANG1005 for Individual Patients
NCT02755987 ·Status: NO_LONGER_AVAILABLE
-
Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
NCT02490878 ·Status: TERMINATED ·Phase: PHASE2
-
Preoperative Stereotactic Radiosurgery for Brain Metastases
NCT04503772 ·Status: COMPLETED ·Phase: PHASE2
-
Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
NCT04763031 ·Status: TERMINATED ·Phase: NA
-
A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain
NCT01563614 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas
NCT00704080 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Dose Escalation in Patients With 1-3 Unresectable Brain Metastases
NCT02080949 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
NCT05109728 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of AG-120 and AG-881 in Subjects With Low Grade Glioma
NCT03343197 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma
NCT02014844 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
NCT00002708 ·Status: COMPLETED ·Phase: PHASE3
-
Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases
NCT04585724 ·Status: WITHDRAWN ·Phase: PHASE1
-
Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)
NCT04915404 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults
NCT01043536 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants
NCT03649464 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (3*10 Gy) to the Historical Single-dose Radiosurgery (1*20 to 25 Gy) With Medico-economic Evaluation.
NCT05102747 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer With Brain Metastases
NCT02162537 ·Status: TERMINATED ·Phase: PHASE3
-
PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation
NCT01402063 ·Status: COMPLETED ·Phase: PHASE2